Cargando…
Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma
Surgery followed by chemoradiation and adjuvant chemotherapy is standard of care for patients with a glioblastoma (GBM). Due to its limited benefit, an upfront method to predict dismal outcome would prevent unnecessary toxic treatment. We searched for a predictive blood derived biomarker in a cohort...
Autores principales: | van Linde, Myra E., van der Mijn, Johannes C., Pham, Thang V., Knol, Jaco C., Wedekind, Laurine E., Hovinga, Koos E., Aliaga, Esther Sanchez, Buter, Jan, Jimenez, Connie R., Reijneveld, Jaap C., Verheul, Henk M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992035/ https://www.ncbi.nlm.nih.gov/pubmed/27444431 http://dx.doi.org/10.1007/s11060-016-2178-x |
Ejemplares similares
-
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2022) -
LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas
por: Vanderheijden, Cas, et al.
Publicado: (2022) -
Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells
por: Poel, Dennis, et al.
Publicado: (2019) -
Microenvironment involved in FPR1 expression by human glioblastomas
por: Boer, J. C., et al.
Publicado: (2015) -
Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
por: Labots, Mariette, et al.
Publicado: (2020)